TickerFacts.

Company research / HUM

Humana Inc (HUM)

Build a valuation ↗↓ Download CSV

SEC name HUMANA INC · CIK 0000049071 · NYSE · Hospital & Medical Service Plans

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Humana Inc reported revenue of $129.66B. Revenue grew 10.1% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $137.20B.

Key ratios (year ended 2025-12-31)

2.1%
Operating margin
0.9%
Net margin
6.7%
Return on year-end equity
10.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-13

Headquarters locality: Louisville · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-03-31		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$137.20B$129.66B$117.76B$106.37B$92.87B$83.06B$77.16B$64.89B$56.91B$53.77B$54.38B
Operating Income$2.44B$2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B
Depreciation & Amortization$678.00M$698.00M$839.00M$779.00M$709.00M$596.00Mn/an/a$444.00M$410.00M$388.00M
EBITDA$3.12B$3.40B$3.40B$4.79B$4.51B$3.74Bn/an/a$3.54B$4.67B$2.13B
Net Income$1.13B$1.19B$1.21B$2.49B$2.81B$2.93B$3.37B$2.71B$1.68B$2.45B$614.00M
EPS (Diluted)n/a$9.84$9.98$20.00$22.08$22.67$25.31$20.10$12.16$16.81$4.07
Total Assets$55.28B$48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B
Total Liabilities$36.63B$31.17B$30.03B$30.75B$27.68B$28.25B$21.24B$17.04B$15.25B$17.34B$14.71B
Shareholders' Equity$18.58B$17.66B$16.38B$16.26B$15.31B$16.08B$13.73B$12.04B$10.16B$9.84B$10.69B
Cash & Equivalents$4.95B$4.20B$2.22B$4.69B$5.06B$3.39B$4.67B$4.05B$2.34B$4.04B$3.88B
Operating Cash Flow$1.84B$921.00M$2.97B$3.98B$4.59B$2.26B$5.64B$5.28B$2.17B$4.05B$1.94B
Capital Expenditures$572.00M$546.00M$575.00M$1.00B$1.14B$1.34B$964.00M$736.00M$612.00M$524.00M$527.00M
Free Cash Flow$1.27B$375.00M$2.39B$2.98B$3.45B$920.00M$4.67B$4.55B$1.56B$3.53B$1.41B
Share Repurchases$249.00M$151.00M$817.00M$1.57B$2.10B$79.00M$1.82B$1.07B$1.09B$3.37B$104.00M
Dividends Paid$429.00M$430.00M$431.00M$431.00M$392.00M$354.00M$323.00M$291.00M$265.00M$220.00M$177.00M
Dividends Per Sharen/a$3.54$3.54$3.44$3.06$2.73$2.43$2.15$1.90$1.49$1.16
Weighted Average Diluted Sharesn/a120.83M120.87M124.44M127.09M129.40M133.01M134.73M138.40M145.59M150.92M
EPS (Basic)n/a$9.87$10.01$20.09$22.20$22.79$25.47$20.20$12.24$16.94$4.11

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView